Liposome microemulsion containing nano cross-linked hyaluronic acid as well as preparation method and application thereof
A technology for cross-linking hyaluronic acid and hyaluronic acid, which is applied in the directions of liposome delivery, medical preparations of inactive ingredients, pharmaceutical formulations, etc., can solve the problem of poor use value and insufficient storage stability of liquid crystal drug delivery systems. Long, unable to form shelf life products and other problems, to prevent wrinkles, delay skin aging around the eyes, and smooth fine lines
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0053] (Example 1, liposome solution containing hyaluronic acid)
[0054] The liposome solution containing hyaluronic acid of the present embodiment, the liposome solution is a microemulsion, and the liposome solution is composed of the following components by weight percentage: phospholipid 1%, cholesterol 0.2%, nano-crosslinked hyaluronic acid Acid or its sodium salt 0.1%, Tween 800.20%, water balance.
[0055] The pharmaceutical surfactant used in this embodiment is Tween 80, and the pharmaceutical surfactant can also be selected from Span and Poloxamer.
[0056] The phospholipid is soybean lecithin.
[0057] The nano-crosslinked hyaluronic acid or its sodium salt raw material is prepared by the method of the Chinese patent document entitled "Nano-crosslinked sodium hyaluronate gel and its preparation method and application" filed by the applicant in 2016 Cross-linked sodium hyaluronate gel with an average particle size of 100nm to 250nm.
[0058] The preparation method ...
Embodiment 2 to Embodiment 8
[0065] (Example 2 to Example 8, liposome solution containing hyaluronic acid)
[0066] See Table 1 for the composition of the liposome solutions containing hyaluronic acid in Examples 2 to 8.
[0067] Table 1 Composition of liposome solution containing hyaluronic acid (wt%)
[0068]
[0069] See Table 2 for the average particle diameter, zeta potential, and osmotic pressure of the liposome solutions of Examples 1 to 8.
[0070] The measuring instruments of average particle diameter, zeta potential and osmotic pressure are the same as in Example 1.
[0071] Table 2
[0072]
[0073] From the detection results, the liposome solution of the present invention has high absolute value of zeta potential, high system stability, and the storage time can be as long as more than 24 months.
Embodiment 9
[0074] (Example 9, the preparation method of the liposome solution containing hyaluronic acid)
[0075] What the preparation method of the present embodiment prepared is the liposome solution containing hyaluronic acid of embodiment 1, comprises the following steps:
[0076] ① Dissolve the phospholipids, cholesterol and Tween 80 weighed according to weight percentage in ethanol, shake well to obtain lipid solution.
[0077] ②Mix the nano-crosslinked sodium hyaluronate gel with water as a dispersant evenly to obtain a hydration solution.
[0078] ③ Mix the lipid solution obtained in step ① with the hydration solution in step ②, and stir to obtain a microemulsion; the microemulsion is distilled under reduced pressure at 45°C to remove ethanol; the microemulsion after alcohol removal is passed through a high-pressure homogenizer, A liposome microemulsion solution containing hyaluronic acid is obtained.
PUM
| Property | Measurement | Unit |
|---|---|---|
| particle diameter | aaaaa | aaaaa |
| particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


